Proto Labs (NYSE:PRLB - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Thursday, July 31st. Analysts expect Proto Labs to post earnings of $0.33 per share and revenue of $128.05 million for the quarter. Proto Labs has set its Q2 2025 guidance at 0.300-0.380 EPS.
Proto Labs (NYSE:PRLB - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The industrial products company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.29 by $0.04. Proto Labs had a net margin of 2.99% and a return on equity of 2.22%. The company had revenue of $126.21 million during the quarter, compared to analyst estimates of $123.71 million. During the same quarter in the previous year, the firm earned $0.40 EPS. The firm's revenue was down 1.3% compared to the same quarter last year. On average, analysts expect Proto Labs to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Proto Labs Price Performance
PRLB stock traded up $0.31 during trading on Friday, hitting $39.05. The stock had a trading volume of 104,588 shares, compared to its average volume of 214,279. Proto Labs has a twelve month low of $25.75 and a twelve month high of $46.73. The stock has a market capitalization of $928.22 million, a P/E ratio of 65.08 and a beta of 1.33. The company's 50-day moving average price is $39.14 and its two-hundred day moving average price is $38.44.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Tuesday, May 6th.
Get Our Latest Stock Report on PRLB
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of PRLB. AQR Capital Management LLC grew its position in Proto Labs by 3.3% in the 1st quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company's stock valued at $2,238,000 after acquiring an additional 2,040 shares in the last quarter. Royal Bank of Canada grew its position in Proto Labs by 51.3% in the 1st quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company's stock valued at $228,000 after acquiring an additional 2,207 shares in the last quarter. Finally, NewEdge Advisors LLC grew its position in Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock valued at $26,000 after acquiring an additional 738 shares in the last quarter. Hedge funds and other institutional investors own 84.54% of the company's stock.
Proto Labs Company Profile
(
Get Free Report)
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
Recommended Stories
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
